Preferred Label : Pertuzumab/Trastuzumab/Docetaxel Followed by FEC Regimen;
NCIt synonyms : Pertuzumab Trastuzumab Docetaxel Followed by FEC; Pertuzumab Trastuzumab Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide; Pertuzumab-Trastuzumab-Docetaxel Followed by Fluorouracil-Epirubicin-Cyclophosphamide; Pertuzumab/Trastuzumab/Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide;
NCIt definition : A regimen consisting of pertuzumab, trastuzumab and docetaxel, followed by fluorouracil,
epirubicin and intravenous cyclophosphamide, used as a neoadjuvant or adjuvant treatment
for HER-2/neu-positive breast cancer.;
NCIt note : Source: NCCN Guidelines 2017;
NCI Metathesaurus CUI : CL524993;
Origin ID : C138044;
UMLS CUI : C4527350;
Semantic type(s)
chemotherapy_regimen_has_component
concept_is_in_subset